Yusuf Erkul

Harnessing Suitable Model Systems for the Testing & Development of Influenza Vaccines with Longevity & Efficacy at Low Doses – Chair

Supercharging mRNA Immunotherapies with Improved Expression & Immunogenicity Towards Translatable & Clinically Ready Drugs